BioCryst公司的贝罗司他胶囊治疗效果好吗

Orladeyo prevents hereditary angioedema (HAE) in adults and pediatric patients over 12 years of age. Orladeyo is a new, oral, once-daily, potent, selective human plasma kallikrein inhibitor that prevents edema attacks by inhibiting kallikrein to prevent the production of bradykinin.

Berostat capsule Orladeyo is the first targeted oral therapy approved to prevent HAE attacks. The approval of Orladeyo will bring significant progress in the treatment of HAE patients with hereditary angioedema and will help reduce the treatment burden on patients.

BioCryst Corporation is a biotechnology company. BioCryst designs, optimizes and develops small molecule drugs that block enzymes involved in disease pathogenesis. The company focuses on treating rare diseases. BioCryst uses X-ray scattering technology, molecular structure computer simulations and chemical techniques to focus on the three-dimensional molecular structure and active site characteristics of enzymes that control cell biology. Are BioCryst's berosostat capsules effective?

In the pivotal Phase 3 APeX-2 trial, BioCryst significantly reduced the number of hereditary angioedema HAE attacks over 24 weeks and continued through week 48. Patients who completed the 48-week trial experienced a significant reduction in the frequency of hereditary angioedema HAE attacks, from an average of 2.9 attacks/month at baseline to an average of 1 attack/month. Completion of another long-term open-label APeX-S study reduced the frequency of HAE attacks in patients with hereditary angioedema to an average of 0.8 episodes per month. It can be seen that the therapeutic effect of beroxostat capsule Orladeyo is very significant, and the successful development of this drug is good news for many patients.

The above is the introduction about Orladeyo. If patients have other questions about Orladeyo (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/96519.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.